75 related articles for article (PubMed ID: 8645034)
1. [Immunohistochemistry and activities of thymidine phosphorylase in the tissues of uterine cervical and endometrial carcinomas].
Kamoi S; Kawamoto M; Ohta Y; Takahashi H; Araki T
Gan To Kagaku Ryoho; 1996 May; 23(6):801-4. PubMed ID: 8645034
[No Abstract] [Full Text] [Related]
2. A role of thymidine phosphorylase and P53 tissue protein expression in biology of endometrial cancer.
Mazurek A; Kuć P; Mazurek-Wadołkowska E; Laudański T
Neoplasma; 2008; 55(3):261-5. PubMed ID: 18348659
[TBL] [Abstract][Full Text] [Related]
3. [Sentinel lymph node biopsy in cervical and endometrial cancers: a feasibility study].
Lelièvre L; Camatte S; Le Frère-Belda MA; Kerrou K; Froissart M; Taurelle R; Vildé F; Lécuru F
Bull Cancer; 2004 Apr; 91(4):379-84. PubMed ID: 15242323
[TBL] [Abstract][Full Text] [Related]
4. Frozen section examination of pelvic lymph nodes in endometrial and cervical cancer: accuracy in patients submitted to neoadjuvant treatments.
Fanfani F; Ludovisi M; Zannoni GF; Distefano M; Fagotti A; Ceccaroni M; Mancuso S; Scambia G
Gynecol Oncol; 2004 Sep; 94(3):779-84. PubMed ID: 15350373
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of tumor angiogenesis and thymidine phosphorylase tissue expression in patients with endometrial cancer.
Mazurek A; Kuc P; Terlikowski S; Laudanski T
Neoplasma; 2006; 53(3):242-6. PubMed ID: 16652195
[TBL] [Abstract][Full Text] [Related]
6. Pyrimidine nucleoside phosphorylase activity in normal tissues of the uterus and ovary and in benign and malignant lesions of these organs.
Suzuki M; Usui N; Furugen Y; Mitsuhasi N
Int J Clin Oncol; 2001 Feb; 6(1):19-24. PubMed ID: 11706522
[TBL] [Abstract][Full Text] [Related]
7. [Expression of thymidine phosphorylase in cancer].
Jiang LN; Yu SY; Xiong HH; Zhang MX
Zhonghua Zhong Liu Za Zhi; 2004 May; 26(5):297-9. PubMed ID: 15312368
[TBL] [Abstract][Full Text] [Related]
8. Enzymatic activities of uridine and thymidine phosphorylase in normal and cancerous uterine cervical tissues.
Kobayashi Y; Wada Y; Ohara T; Okuda Y; Suzuki N; Hasegawa K; Kiguchi K; Ishizuka B
Hum Cell; 2007 Nov; 20(4):107-10. PubMed ID: 17949350
[TBL] [Abstract][Full Text] [Related]
9. Expression of thymidine phosphorylase in human cervical cancer.
Hata K; Takebayashi Y; Iida K; Fujiwaki R; Fukumoto M; Miyazaki K
Anticancer Res; 1999; 19(1B):709-16. PubMed ID: 10216481
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical expression of thymidine phosphorylase in human endometrial cancer.
Fujiwaki R; Hata K; Iida K; Koike M; Miyazaki K
Gynecol Oncol; 1998 Mar; 68(3):247-52. PubMed ID: 9570975
[TBL] [Abstract][Full Text] [Related]
11. Laparoscopic detection of sentinel lymph nodes using blue dye in women with cervical and endometrial cancer.
Holub Z; Jabor A; Lukac J; Kliment L
Med Sci Monit; 2004 Oct; 10(10):CR587-91. PubMed ID: 15448599
[TBL] [Abstract][Full Text] [Related]
12. Clinical implication of expression of platelet-derived endothelial cell growth factor (PD-ECGF) in metastatic lesions of uterine cervical cancers.
Fujimoto J; Sakaguchi H; Hirose R; Wen H; Tamaya T
Cancer Res; 1999 Jul; 59(13):3041-4. PubMed ID: 10397240
[TBL] [Abstract][Full Text] [Related]
13. Thymidine phosphorylase expression is predominantly observed in stroma of well-differentiated adenocarcinoma of endometrium and correlates with a frequency of vascular involvement.
Sakamoto H; Shirakawa T; Izuka S; Igarashi T; Kinoshita K; Ohtani K; Takami T; Nakayama Y; Teramoto K; Satoh K
Gynecol Oncol; 1999 Mar; 72(3):298-305. PubMed ID: 10053099
[TBL] [Abstract][Full Text] [Related]
14. The sentinel node in gynaecological malignancies.
Balega J; Van Trappen PO
Cancer Imaging; 2006 Feb; 6(1):7-15. PubMed ID: 16520291
[TBL] [Abstract][Full Text] [Related]
15. Routes of lymphatic spread: a study of 112 consecutive patients with endometrial cancer.
Mariani A; Webb MJ; Keeney GL; Podratz KC
Gynecol Oncol; 2001 Apr; 81(1):100-4. PubMed ID: 11277658
[TBL] [Abstract][Full Text] [Related]
16. [Study on cytokeratin and CA125 for diagnosing lymph node micrometastases in endometrial cancer].
Liu FH; Wang YF; Wang J; Xue Q; Jiang S; Ma YY
Zhonghua Fu Chan Ke Za Zhi; 2004 Sep; 39(9):612-5. PubMed ID: 15498190
[TBL] [Abstract][Full Text] [Related]
17. Lymphatic vessel density as a prognostic indicator for patients with stage I cervical carcinoma.
Gao P; Zhou GY; Yin G; Liu Y; Liu ZY; Zhang J; Hao CY
Hum Pathol; 2006 Jun; 37(6):719-25. PubMed ID: 16733213
[TBL] [Abstract][Full Text] [Related]
18. Thymidine phosphorylase activity in normal, hyperplastic and neoplastic endometrium--correlation with intratumoral angiogenesis.
Sivridis E
Adv Exp Med Biol; 2000; 476():297-303. PubMed ID: 10949674
[No Abstract] [Full Text] [Related]
19. Endometrial carcinomas with lymph node involvement: novel histopathologic factors for predicting prognosis.
Yasunaga M; Yamasaki F; Tokunaga O; Iwasaka T
Int J Gynecol Pathol; 2003 Oct; 22(4):341-6. PubMed ID: 14501813
[TBL] [Abstract][Full Text] [Related]
20. Occult lymph node metastases detected by cytokeratin immunohistochemistry predict recurrence in node-negative endometrial cancer.
Yabushita H; Shimazu M; Yamada H; Sawaguchi K; Noguchi M; Nakanishi M; Kawai M
Gynecol Oncol; 2001 Feb; 80(2):139-44. PubMed ID: 11161851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
